{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:24:23Z","timestamp":1790605463777,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.euroneuro.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T02:07:07Z","timestamp":1626314827000},"page":"106-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies"],"prefix":"10.1016","volume":"51","author":[{"given":"Dimitri","family":"Daldegan-Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas O.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2021.06.002_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of Cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report","volume":"49","author":"Abrams","year":"2018","journal-title":"Eur. J. Internal Med."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0002","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2007.04.049","article-title":"Crack whips the heart: a review of the cardiovascular toxicity of cocaine","volume":"100","author":"Afonso","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.euroneuro.2021.06.002_bib0003","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1176\/appi.ajp.162.8.1507","article-title":"Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study","volume":"162","author":"Aharonovich","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0004","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2011.03.001","article-title":"Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use","volume":"118","author":"Alessi","year":"2011","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0005","first-page":"382","article-title":"\u2018What a pity!\u2019 \u2013 Exploring the use of \u2018pitilho\u2019 as harm reduction among crack users in Salvador, Brazil","volume":"18","author":"Andrade","year":"2011","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0007","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/pr.111.005124","article-title":"Individual differences and social influences on the neurobehavioral pharmacology of abused drugs","volume":"65","author":"Bardo","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0008","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/ajad.12578","article-title":"Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?","volume":"26","author":"Butelman","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0009","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.drugalcdep.2017.08.036","article-title":"Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses","volume":"180","author":"Butler","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"14","key":"10.1016\/j.euroneuro.2021.06.002_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24142583","article-title":"Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms","volume":"24","author":"Calpe-L\u00f3pez","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/0269881120965952","article-title":"Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice","author":"Calpe-L\u00f3pez","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0012","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1590\/S0034-89102011005000066","article-title":"Crack cocaine craving: behaviors and coping strategies among current and former users","volume":"45","author":"Chaves","year":"2011","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173065","article-title":"Cannabidiol (CBD) reduces cocaine-environment memory in mice","volume":"199","author":"Chesworth","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0014","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1360-0443.2003.00376.x","article-title":"Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990\u201398","volume":"98","author":"Coffin","year":"2003","journal-title":"Addiction"},{"issue":"79","key":"10.1016\/j.euroneuro.2021.06.002_bib0015","article-title":"Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs","volume":"4","author":"Connor","year":"2013","journal-title":"Front. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0016","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/YCO.0000000000000069","article-title":"Polysubstance use: diagnostic challenges, patterns of use and health","volume":"27","author":"Connor","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0740-5472(01)00192-1","article-title":"Cocaine dependence: a disease of the brain's reward centers","volume":"21","author":"Dackis","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0019","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addict. Biol."},{"issue":"2-3","key":"10.1016\/j.euroneuro.2021.06.002_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2010.07.026","article-title":"Mortality among cocaine users: a systematic review of cohort studies","volume":"113","author":"Degenhardt","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"9904","key":"10.1016\/j.euroneuro.2021.06.002_bib0021","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"Lancet North Am. Ed."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0022","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pbb.2011.09.003","article-title":"Pretreatment with \u03949-tetrahydrocannabinol (THC) increases cocaine-stimulated activity in adolescent but not adult male rats","volume":"100","author":"Dow-Edwards","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3-4","key":"10.1016\/j.euroneuro.2021.06.002_bib0023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1300\/J175v02n03_08","article-title":"Crack heads and roots daughters: the therapeutic use of cannabis in Jamaica","volume":"2","author":"Dreher","year":"2002","journal-title":"J. Cannabis Therapeutics"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0024","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","article-title":"Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against","volume":"98","author":"Epstein","year":"2003","journal-title":"Addiction"},{"issue":"10209","key":"10.1016\/j.euroneuro.2021.06.002_bib0025","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: challenges and opportunities","volume":"394","author":"Farrell","year":"2019","journal-title":"Lancet North Am. Ed."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-009-1671-8","article-title":"Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse","volume":"207","author":"Feltenstein","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0027","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2015.01.002","article-title":"Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies","volume":"26","author":"Fischer","year":"2015","journal-title":"Int. J. Drug Policy"},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0028","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.drugpo.2013.09.003","article-title":"Crack across the Americas - a massive problem in continued search of viable answers: exemplary views from the North (Canada) and the South (Brazil)","volume":"24","author":"Fischer","year":"2013","journal-title":"Int. J. Drug Policy"},{"issue":"12","key":"10.1016\/j.euroneuro.2021.06.002_bib0029","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.drugpo.2015.09.005","article-title":"Addressing the stimulant treatment gap: a call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use","volume":"26","author":"Fischer","year":"2015","journal-title":"Int. J. Drug Policy"},{"issue":"8","key":"10.1016\/j.euroneuro.2021.06.002_bib0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2017.303818","article-title":"Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations","volume":"107","author":"Fischer","year":"2017","journal-title":"Am. J. Public Health"},{"issue":"1-3","key":"10.1016\/j.euroneuro.2021.06.002_bib0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2008.07.004","article-title":"Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals","volume":"99","author":"Ford","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.06.002_bib0032","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0033","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1254\/jphs.FMJ04003X2","article-title":"New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application","volume":"96","author":"Fujiwara","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107740","article-title":"Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT(1A) and TRPV1 receptor mechanisms","volume":"167","author":"Galaj","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0035","article-title":"Cannabidiol modulates behavioural and gene expression alterations induced by spontaneous cocaine withdrawal","author":"Gasparyan","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.06.002_bib0036","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1038\/sj.npp.1301648","article-title":"Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant","volume":"33","author":"Gerdeman","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addbeh.2017.03.025","article-title":"Cannabis and cue-induced craving in cocaine-dependent individuals: a pilot study","volume":"73","author":"Giasson-Gari\u00e9py","year":"2017","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0038","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/08897077.2017.1389799","article-title":"Mortality risk in a sample of emergency department patients who use cocaine with alcohol and\/or cannabis","volume":"39","author":"Gilmore","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0039","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuro.2015.08.007","article-title":"Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: possible role of the mTOR pathway and reduction in glutamate release","volume":"50","author":"Gobira","year":"2015","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semdp.2008.12.001","article-title":"Cocaine: History, social implications, and toxicity: a review","volume":"26","author":"Goldstein","year":"2009","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0041","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12889-015-2063-0","article-title":"Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: a qualitative study","volume":"15","author":"Gon\u00e7alves","year":"2015","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.06.002_bib0042","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0043","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fpsyt.2012.00092","article-title":"The influence of baseline marijuana use on treatment of cocaine dependence: application of an informative-priors bayesian approach","volume":"3","author":"Green","year":"2012","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-019-00986-2","article-title":"Cannabis use and mental health: risks and benefits","volume":"269","author":"Hall","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00406-019-01068-z","article-title":"Cannabis use and psychosis: a review of reviews","volume":"270","author":"Hasan","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"24","key":"10.1016\/j.euroneuro.2021.06.002_bib0046","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.06.002_bib0047","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jamapsychiatry.2020.1035","article-title":"Association of high-potency cannabis use with mental health and substance use in adolescence","volume":"77","author":"Hines","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2021.06.002_bib0048","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0049","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.119.263707","article-title":"Cannabinoid modulation of food-cocaine choice in male Rhesus monkeys","volume":"373","author":"John","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.06.002_bib0051","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1369-1600.2012.00483.x","article-title":"Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus","volume":"18","author":"Katsidoni","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0052","first-page":"1","article-title":"Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis","author":"Kiburi","year":"2021","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0053","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003023.pub2","article-title":"Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders","author":"Knapp","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0054","doi-asserted-by":"crossref","first-page":"413","DOI":"10.31887\/DCNS.2007.9.4\/nkogan","article-title":"Cannabinoids in health and disease","volume":"9","author":"Kogan","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.06.002_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00952990.2016.1209513","article-title":"Interactions between nicotine and drugs of abuse: a review of preclinical findings","volume":"43","author":"Kohut","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"262","key":"10.1016\/j.euroneuro.2021.06.002_bib0056","article-title":"Understanding addiction using animal models","volume":"13","author":"Kuhn","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0057","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02791072.1999.10471776","article-title":"Therapeutic use of cannabis by crack addicts in Brazil","volume":"31","author":"Labigalini","year":"1999","journal-title":"J. Psychoactive Drugs"},{"issue":"20","key":"10.1016\/j.euroneuro.2021.06.002_bib0058","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0059","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/dar.12275","article-title":"A safer alternative: Cannabis substitution as harm reduction","volume":"34","author":"Lau","year":"2015","journal-title":"Drug Alcohol Rev."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: Review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"163","key":"10.1016\/j.euroneuro.2021.06.002_bib0061","article-title":"Do cannabis users reduce their THC dosages when using more potent cannabis products? A review","volume":"12","author":"Leung","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0062","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pscychresns.2005.09.002","article-title":"Recent cannabis abuse decreased stress-induced BOLD signals in the frontal and cingulate cortices of cocaine dependent individuals","volume":"140","author":"Li","year":"2005","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0063","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Revista Brasileira de Psiquiatria"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0064","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/00952990902933860","article-title":"Cocaine dependence and concurrent marijuana use: a comparison of clinical characteristics","volume":"35","author":"Lindsay","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/15504263.2020.1849887","article-title":"Cocaine and marijuana polysubstance use and cocaine use disorder: investigating mediated effects through patterns of cocaine use","volume":"17","author":"Liu","year":"2021","journal-title":"J. Dual Diagnosis"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0066","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2018.07.025","article-title":"The importance of considering polysubstance use: lessons from cocaine research","volume":"192","author":"Liu","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0067","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.euroneuro.2020.03.012","article-title":"Adolescent cannabis use, cognition, brain health and educational outcomes: a review of the evidence","volume":"36","author":"Lorenzetti","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.06.002_bib0068","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/16066359.2012.733465","article-title":"Cannabis as a substitute for alcohol and other drugs: a dispensary-based survey of substitution effect in Canadian medical cannabis patients","volume":"21","author":"Lucas","year":"2013","journal-title":"Addict. Res. Theory"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0069","doi-asserted-by":"crossref","first-page":"e12778","DOI":"10.1111\/adb.12778","article-title":"The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake","volume":"25","author":"Luj\u00e1n","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Luj\u00e1n","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0071","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0072","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0073","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0074","doi-asserted-by":"crossref","first-page":"E339","DOI":"10.9778\/cmajo.20180023","article-title":"The adverse health effects and harms related to marijuana use: an overview review","volume":"6","author":"Memedovich","year":"2018","journal-title":"CMAJ Open"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0075","article-title":"Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study","author":"Meneses-Gaya","year":"2020","journal-title":"Brazilian J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0076","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1300\/J175v04n01_04","article-title":"Cannabis as a substitute for alcohol: a harm-reduction approach","volume":"4","author":"Mikuriya","year":"2004","journal-title":"J. Cannabis Therapeutics"},{"issue":"9","key":"10.1016\/j.euroneuro.2021.06.002_bib0077","article-title":"Psychosocial interventions for psychostimulant misuse","volume":"9","author":"Minozzi","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0078","doi-asserted-by":"crossref","DOI":"10.1111\/add.15417","article-title":"Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial","author":"Mongeau-P\u00e9russe","year":"2021","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.euroneuro.2021.06.002_bib0079","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugpo.2017.07.012","article-title":"I love having benzos after my coke shot\u201d: the use of psychotropic medication among cocaine users in downtown Montreal","volume":"49","author":"Motta-Ochoa","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0081","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"M\u00fcller","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0082","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0083","series-title":"The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research","year":"2017"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0084","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/026988119801200103","article-title":"Conditioning factors in drug abuse: can they explain compulsion?","volume":"12","author":"O'Brien","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107642","article-title":"Distinct effects of cocaine and cocaine\u202f+\u202fcannabis on neurocognitive functioning and abstinence: a six-month follow-up study","volume":"205","author":"Oliveira","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0086","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1590\/S0034-89102008000400012","article-title":"Characterization of the crack cocaine culture in the city of S\u00e3o Paulo: a controlled pattern of use","volume":"42","author":"Oliveira","year":"2008","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0087","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0088","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.npp.1301109","article-title":"Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats","volume":"32","author":"Panlilio","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0089","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.06.002_bib0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.06.002_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236243","article-title":"Something that actually works\u201d: cannabis use among young people in the context of street entrenchment","volume":"15","author":"Paul","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.06.002_bib0092","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.02.027","article-title":"Social modulation of drug use and drug addiction","volume":"159","author":"Pelloux","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0094","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874473711003010049","article-title":"Review of treatment for cocaine dependence","volume":"3","author":"Penberthy","year":"2010","journal-title":"Curr. Drug Abuse Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0095","first-page":"141","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"JBI Evidence Implementation"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0096","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence","volume":"9","author":"Prud'homme","year":"2015","journal-title":"Substance Abuse"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0097","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-3565(24)37716-X","article-title":"Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat","volume":"286","author":"Pulvirenti","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0098","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2046-4053-4-6","article-title":"Better duplicate detection for systematic reviewers: evaluation of systematic review assistant-deduplication module","volume":"4","author":"Rathbone","year":"2015","journal-title":"System. Rev."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.06.002_bib0099","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0006-2952(01)00616-5","article-title":"Cannabinoid-induced alterations in brain disposition of drugs of abuse","volume":"61","author":"Reid","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1533210107301834","article-title":"Medical cannabis patients: patient profiles and health care utilization patterns","volume":"12","author":"Reiman","year":"2007","journal-title":"Complement. Health Practice Rev."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7517-6-35","article-title":"Cannabis as a substitute for alcohol and other drugs","volume":"6","author":"Reiman","year":"2009","journal-title":"Harm Red. J."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0102","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/1471-2458-10-671","article-title":"Surviving crack: a qualitative study of the strategies and tactics developed by Brazilian users to deal with the risks associated with the drug","volume":"10","author":"Ribeiro","year":"2010","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/adb.12508","article-title":"Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation","volume":"23","author":"Robinson","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172982","article-title":"Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review","volume":"196","author":"Rodrigues","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.06.002_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuroscience.2007.10.026","article-title":"\u03949-Tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons","volume":"151","author":"Sano","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0106","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/1874473711205040006","article-title":"Efficacy of contingency management for cocaine dependence treatment: a review of the evidence","volume":"5","author":"Schierenberg","year":"2012","journal-title":"Curr. Drug Abuse Rev."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.06.002_bib0107","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamapsychiatry.2018.0335","article-title":"Association of cannabis with cognitive functioning in adolescents and young adults: A systematic review and meta-analysis","volume":"75","author":"Scott","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2006.06.012","article-title":"Psychosocial approaches to psychostimulant dependence: a systematic review","volume":"32","author":"Shearer","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728214.2015.985203","article-title":"Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy","volume":"20","author":"Shorter","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addbeh.2017.04.006","article-title":"Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis","volume":"72","author":"Soc\u00edas","year":"2017","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/JCP.0b013e318172b8bc","article-title":"Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: Results from a placebo-controlled, double-blind trial","volume":"28","author":"Soyka","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","article-title":"Animal models of addiction","volume":"19","author":"Spanagel","year":"2017","journal-title":"Dialog. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0113","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","article-title":"Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions","volume":"22","author":"Spanagel","year":"2020","journal-title":"Dialog. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2021.06.002_bib0114","first-page":"2393","article-title":"Crack users: developing strategies to face the risks of the consumption","volume":"7","author":"Teixeira","year":"2015","journal-title":"Revista de Pesquisa"},{"issue":"7","key":"10.1016\/j.euroneuro.2021.06.002_bib0115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0116","series-title":"World Drug Report 2020","year":"2020"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.06.002_bib0117","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.104.080739","article-title":"Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice","volume":"314","author":"Varvel","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0118","article-title":"Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine","author":"Vilela","year":"2015","journal-title":"Mediat. Inflammat., 2015"},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0119","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000599","article-title":"Association between recent cannabis consumption and withdrawal-related symptoms during early abstinence among females with smoked cocaine use disorder","author":"Viola","year":"2020","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2014.09.003","article-title":"Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence","volume":"144","author":"Viola","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"23","key":"10.1016\/j.euroneuro.2021.06.002_bib0121","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2021.06.002_bib0122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: a guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clin. Psychol. Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.06.002_bib0123","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/0003-4819-119-3-199308010-00009","article-title":"Cocaine abuse","volume":"119","author":"Warner","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.06.002_bib0124","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.addbeh.2013.01.001","article-title":"The topography of multiple drug use among adolescent Australians: findings from the National Drug Strategy Household Survey","volume":"38","author":"White","year":"2013","journal-title":"Addict. Behav."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.06.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.02.106","article-title":"Cannabinoids rescue cocaine-induced seizures by restoring brain glycine receptor dysfunction","volume":"30","author":"Zou","year":"2020","journal-title":"Cell Rep."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:01:53Z","timestamp":1760378513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21002510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":125,"alternative-id":["S0924977X21002510"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.06.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}